Phase II/ III Clinical Trials of Imigliptin Hydr...
XuanZhu Pharma Co., Ltd. is an international research and development (R&D) enterprise of innovative drugs. Founded in 2002 with the registered capital of 50 million yuan，XuanZhu Pharma is focused on R&D of new chemical entities. It is a wholly-owned subsidiary and innovative drug research institute of Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharma). Sihuan Pharma, listed in Hong Kong (stock code: 00460.HK) on October 28, 2010, has developed into a multi-functional pharmaceutical group company, covering ...
